The inhibition of CK1 using PF-670462 significantly prolonged the overall survival of a CLL mouse model and had synergistic effects with the B-cell receptor (BCR) inhibitor ibrutinib in both in vitro and in vivo CLL [135]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.